DRMA - Dermata Therapeutics, Inc.
1.25
0.040 3.200%
Share volume: 119,390
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.04
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-07-2024 | 11-13-2024 | 03-17-2025 | 05-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 3.204 M | 2.884 M | 3.226 M | 3.200 M | 2.340 M | 1.761 M | |
| Selling general and admin | 1.603 M | 874.640 K | 824.294 K | 1.008 M | 1.059 M | 1.256 M | |
| Research and development | 1.601 M | 2.009 M | 2.401 M | 2.192 M | 1.281 M | 504.387 K | |
| Total expenses | 3.204 M | 2.884 M | 3.226 M | 3.200 M | 2.340 M | 1.761 M | |
| -9.98% | 11.86% | -0.79% | -26.89% | -24.75% | |||
| Operating income | -3.204 M | -2.884 M | -3.226 M | -3.200 M | -2.340 M | -1.761 M | |
| Ebit | -3.204 M | -2.884 M | -3.226 M | -3.200 M | -2.340 M | -1.761 M | |
| Pretax income | -3.134 M | -2.829 M | -3.173 M | -3.151 M | -2.304 M | -1.692 M | |
| -9.74% | 12.16% | -0.70% | -26.89% | -26.55% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.134 M | -2.829 M | -3.173 M | -3.151 M | -2.304 M | -1.692 M | |
| 9.74% | -12.16% | 0.70% | 26.89% | 26.55% |